Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 08 Oct 2026 for Edwards Lifesciences Corp, €40k. Read the official filing
Filing timeline
BuySaleDaniel J. Lippis
Insider track record
Disclosed buys
0
Disclosed sells
6
Signal history
Daniel J. Lippis: trading record in brief
All filings by Daniel J. Lippis on record concern Edwards Lifesciences Corp, in the capacity of senior executive. We count 38 filings; the first trade dates from 16 February 2024 and the latest from 8 October 2026.
Sales make up the whole of the open-market record (6 sales, €475k). The amount is not disclosed for 1 filing. The rest of the record consists of 13 share grants and 19 option exercises. So far in 2026, the count stands at no purchases and 5 sales.
The record was last updated on 8 October 2026 with an option exercise (€40k) in Edwards Lifesciences Corp. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Daniel J. Lippis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations38 total
619 shares@ US$72.680.0001% mcap2.5% of flowCommon StockSEC:0001225208-26-008338:0
619 shares@ US$85.650.0001% mcap3.0% of flowCommon StockSEC:0001225208-26-008338:1
619 shares@ US$72.680.0001% mcap2.6% of flowCommon StockSEC:0001225208-26-007774:0
619 shares@ US$87.510.0001% mcap3.1% of flowCommon StockSEC:0001225208-26-007774:1
619 shares@ US$72.680.0001% mcap2.6% of flowCommon StockSEC:0001225208-26-007065:0
619 shares@ US$92.030.0001% mcap3.3% of flowCommon StockSEC:0001225208-26-007065:1
619 shares@ US$72.680.0001% mcap2.6% of flowCommon StockSEC:0001225208-26-006576:0
619 shares@ US$91.700.0001% mcap3.3% of flowCommon StockSEC:0001225208-26-006576:1
377 shares@ US$95.180.0001% mcap2.1% of flowCommon StockSEC:0001225208-26-006535:0
619 sharesCommon StockSEC:0001225208-26-006263:0
619 sharesCommon StockSEC:0001225208-26-006263:1
1,019 shares@ US$59.25670.0001% mcap3.5% of flowCommon StockSEC:0001225208-26-004422:0
1,019 shares@ US$59.25673.5% of flowCommon StockSEC:0001225208-26-003538:0
432 shares@ US$79.782.0% of flowCommon StockSEC:0001225208-26-002409:0
12,820 shares0Common StockSEC:0001225208-26-001986:0
1,019 shares@ US$59.25670.0001% mcap3.5% of flowCommon StockSEC:0001225208-26-000558:0
1,019 shares@ US$59.25670.0001% mcap3.4% of flowCommon StockSEC:0001225208-25-009934:0
1,020 shares@ US$59.25673.5% of flowCommon StockSEC:0001225208-25-009066:0
4,114 shares@ US$79.460518.8% of flowCommon StockSEC:0001225208-25-006815:0
333 shares@ US$76.791.5% of flowCommon StockSEC:0001225208-25-006588:0
271 shares@ US$73.681.2% of flowCommon StockSEC:0001225208-25-004997:0
4,225 shares0Common StockSEC:0001225208-25-004947:0
225 shares@ US$75.651.0% of flowCommon StockSEC:0001225208-25-004769:0
300 shares@ US$45.27670.8% of flowCommon StockSEC:0001225208-25-004176:0
400 shares@ US$45.27671.1% of flowCommon StockSEC:0001225208-25-003194:0
25 of 38 declarations
